• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Few-time-points time-integrated activity coefficients calculation using non-linear mixed-effects modeling: Proof of concept for [In]In-DOTA-TATE in kidneys.

作者信息

Subangun Rizky Mahardhika, Hardiansyah Deni, Ibrahim Raushan Fikr Ilham, Patrianesha Bisma Barron, Hidayati Nur Rahmah, Beer Ambros J, Glatting Gerhard

机构信息

Medical Physics and Biophysics, Physics Department, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Depok, Indonesia.

Medical Physics and Biophysics, Physics Department, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Depok, Indonesia.

出版信息

Phys Med. 2025 Jan;129:104865. doi: 10.1016/j.ejmp.2024.104865. Epub 2024 Dec 3.

DOI:10.1016/j.ejmp.2024.104865
PMID:39631133
Abstract

PURPOSE

The purpose of this study is to investigate the accuracy of few-time-points (FTP) time-integrated activity coefficients (TIACs) in peptide-receptor radionuclide therapy (PRRT) using non-linear mixed-effects (NLME) modeling.

METHODS

Biokinetic data of [In]In-DOTA-TATE in kidneys at T-1 = (2.9 ± 0.6) h, T-2 = (4.6 ± 0.4) h, T-3 = (22.8 ± 1.6) h, T-4 = (46.7 ± 1.7) h, and T-5 = (70.9 ± 1.0) h after injection were obtained from eight patients using planar imaging. The Sum-Of-Exponentials (SOE) function with four parameters was used, which was selected as the best model for the renal biokinetic data of [In]In-DOTA-TATE. The parameters of the SOE function were fitted to the all-time-point data in the NLME framework to derive reference (rTIACs). FTP fits, which consist of all combinations of time points, are done to calculate the estimated TIACs (eTIACs). The accuracy of the FTP-NLME TIACs calculations was assessed by calculating the relative deviations (RDs) and relative root-mean-square errors (RMSEs) between the eTIACs and rTIACs.

RESULTS

The lowest (mean ± SD) of RDs for the single-, two-, three-, four-time point FTPs were (0 ± 8) % (T-4), (1 ± 6) % (T-3 and T-4), (3 ± 5) % (T-2, T-3 and T-4), and (0 ± 2) % (T-2, T-3, T-4, and T-5), respectively. The lowest RMSEs for the one-, two-, three-, and four-time point FTPs were 8 % (T-4), 6 % (T-3 and T-4), 5 % (T-2, T-3 and T-4), and 2 % (T-2, T-3, T-4, and T-5), respectively.

CONCLUSION

Our results showed that FTP-NLME in an example of [In]In-DOTA-TATE could lead to a high accuracy of eTIAC across various time points, when incorporating time point T-4 = (46.7 ± 1.7) h.

摘要

相似文献

1
Few-time-points time-integrated activity coefficients calculation using non-linear mixed-effects modeling: Proof of concept for [In]In-DOTA-TATE in kidneys.
Phys Med. 2025 Jan;129:104865. doi: 10.1016/j.ejmp.2024.104865. Epub 2024 Dec 3.
2
Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model.使用非线性混合效应模型单次点估计 PRRT 中的吸收剂量。
Z Med Phys. 2023 Feb;33(1):70-81. doi: 10.1016/j.zemedi.2022.06.004. Epub 2022 Aug 10.
3
Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [Lu]Lu-PSMA-617 Therapy.单次时间点肾脏剂量学使用非线性混合效应模型和基于人群的模型选择在 [Lu]Lu-PSMA-617 治疗中。
J Nucl Med. 2024 Apr 1;65(4):566-572. doi: 10.2967/jnumed.123.266268.
4
Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept.使用模型选择和非线性混合效应建模的单时间点剂量测定法:概念验证
EJNMMI Phys. 2023 Feb 10;10(1):12. doi: 10.1186/s40658-023-00530-1.
5
Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles.估算转移性神经内分泌肿瘤患者体内“直接途径”镥-177-[Lu]Lu-DOTA-TATE PRRT 治疗中正常器官和肿瘤病变部位的吸收剂量:与无载体添加[Lu]Lu-DOTA-TATE 的比较及多周期趋势。
Cancer Biother Radiopharm. 2022 Apr;37(3):214-225. doi: 10.1089/cbr.2021.0340. Epub 2021 Dec 15.
6
Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy.比较转移性神经内分泌肿瘤患者在行肽受体放射性核素治疗前的 177Lu-DOTA-TATE 序列平面断层扫描与 68Ga-DOTA-TATE PET/CT 图像。
Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):501-11. doi: 10.1007/s00259-011-2003-x. Epub 2011 Dec 20.
7
Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling.基于人群的模型选择,用于使用非线性混合效应建模准确估计时间积分活动。
Z Med Phys. 2024 Aug;34(3):419-427. doi: 10.1016/j.zemedi.2023.01.007. Epub 2023 Feb 20.
8
Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors.长效放射性标记生长抑素类似物 Lu-DOTA-EB-TATE 在晚期转移性神经内分泌肿瘤患者中的安全性、药代动力学和剂量学。
J Nucl Med. 2018 Nov;59(11):1699-1705. doi: 10.2967/jnumed.118.209841. Epub 2018 Apr 13.
9
Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours.使用 [Lu]Lu-DOTA-TATE 克服肽受体放射性核素治疗中的肾毒性,用于治疗神经内分泌肿瘤。
Nucl Med Biol. 2021 Nov-Dec;102-103:1-11. doi: 10.1016/j.nucmedbio.2021.06.006. Epub 2021 Jul 1.
10
Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule.肽受体放射性核素治疗中治疗计划准确性对采样方案的依赖性。
EJNMMI Res. 2016 Dec;6(1):30. doi: 10.1186/s13550-016-0185-8. Epub 2016 Mar 25.